We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
Cap. Flow
-$3.6B
Cap. Flow %
-4.89%
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$269M
2
MSFT icon
Microsoft
MSFT
+$172M
3
AMZN icon
Amazon
AMZN
+$114M
4
DIS icon
Walt Disney
DIS
+$62.4M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.8M

Sector Composition

Rank Sector Weight
1 Technology 22.61%
2 Financials 14.26%
3 Healthcare 12.86%
4 Consumer Discretionary 12.27%
5 Industrials 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOFG
2351
DELISTED
MidWestOne Financial Group
MOFG
$686K ﹤0.01%
22,148
-1,255
-5% -$35.7K
SEER icon
2352
Seer Inc
SEER
$120M
$686K ﹤0.01%
+13,720
New +$803K
TCS
2353
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$681K ﹤0.01%
2,730
+694
+34% +$155K
CPLG
2354
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$678K ﹤0.01%
75,029
-3,460
-4% -$28.1K
STFC
2355
DELISTED
State Auto Financial Corp
STFC
$678K ﹤0.01%
34,423
-1,030
-3% -$18.9K
GERN icon
2356
Geron
GERN
$949M
$675K ﹤0.01%
426,967
-14,028
-3% -$25.1K
RIGL icon
2357
Rigel Pharmaceuticals
RIGL
$750M
$675K ﹤0.01%
19,743
-1,304
-6% -$51.6K
KLRS
2358
Kalaris Therapeutics
KLRS
$96.8M
$675K ﹤0.01%
1,255
+390
+45% +$328K
LCI
2359
DELISTED
Lannett Company, Inc.
LCI
$674K ﹤0.01%
31,926
+519
+2% +$13.7K
IMVT icon
2360
Immunovant
IMVT
$8.25B
$673K ﹤0.01%
41,958
-1,755
-4% -$46.3K
RNAM
2361
DELISTED
Avidity Biosciences
RNAM
$666K ﹤0.01%
30,526
+11,214
+58% +$275K
STRO icon
2362
Sutro Biopharma
STRO
$421M
$666K ﹤0.01%
2,925
+154
+6% +$36.5K
ALBO
2363
DELISTED
Albireo Pharma Inc
ALBO
$662K ﹤0.01%
18,766
-970
-5% -$35.8K
HCCI
2364
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$661K ﹤0.01%
24,369
-720
-3% -$18K
QNCX icon
2365
Quince Therapeutics
QNCX
$29.5M
$658K ﹤0.01%
91
-6
-6% -$43.2K
ACRE
2366
Ares Commercial Real Estate
ACRE
$270M
$657K ﹤0.01%
47,866
-3,865
-7% -$50.5K
GDEN
2367
DELISTED
Golden Entertainment
GDEN
$654K ﹤0.01%
25,908
-1,300
-5% -$29.2K
GOGO icon
2368
Gogo Inc
GOGO
$492M
$652K ﹤0.01%
67,452
-5,434
-7% -$64.5K
CVM icon
2369
CEL-SCI Corp
CVM
$30.1M
$651K ﹤0.01%
1,427
-91
-6% -$49.7K
ATEN icon
2370
A10 Networks
ATEN
$1.95B
$648K ﹤0.01%
67,398
-6,172
-8% -$60.4K
SPNE
2371
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$648K ﹤0.01%
37,249
-1,530
-4% -$27.4K
BRG
2372
DELISTED
Bluerock Residential Growth REIT, Inc.
BRG
$647K ﹤0.01%
63,994
-2,612
-4% -$29.4K
SPOK icon
2373
Spok Holdings
SPOK
$241M
$646K ﹤0.01%
61,559
+635
+1% +$7.27K
GIC icon
2374
Global Industrial
GIC
$1.49B
$645K ﹤0.01%
15,674
-1,504
-9% -$59.4K
PTVE
2375
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$645K ﹤0.01%
46,932
+50
+0.1% +$775

Similar funds

RhumbLine Advisers's Q1 2021 Portfolio in Review

As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.

Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.

  • RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
  • RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
  • RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
  • RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
  • RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
  • RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
  • RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.

Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.